The Press of Atlantic City Amgen to buy Horizon Therapeutics in $26.4B deal Jersey Shore • Dec 12, 2022
Daily Mail on New Jersey US STOCKS-Dow, Nasdaq weighed down by Microsoft, Amgen; all eyes on Fed New Jersey Non-Local Sources • Apr 28, 2021
Return On Information New Jersey Legendary pharma exec Hassan to speak at webinar Tuesday New Jersey Business • Dec 21, 2020
The Central Record | Medford Provention Bio Announces Initiation of Phase 2b PROACTIVE Study of PRV-015 (anti-IL-15) in Non-responsive Celiac Disease Delaware River • Aug 31, 2020
UPI on New Jersey Dow to add Salesforce, Amgen, Honeywell next week New Jersey Non-Local Sources • Aug 25, 2020
CNN on New Jersey Major shakeup for the Dow Jones Industrial Average index: 3 new stocks join New Jersey Non-Local Sources • Aug 24, 2020
Daily Mail on New Jersey Amgen patents on top-selling arthritis drug Enbrel upheld, shares rise New Jersey Non-Local Sources • Jul 1, 2020
The Press of Atlantic City Analysis on Impact of Covid-19 - Global Anti-inflammatory Therapeutics Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Amgen Inc. | Technavio Jersey Shore • Apr 3, 2020
The Press of Atlantic City Global Biologics Market: Insight, Competition and Forecast (2020-2025) Featuring Eli Lilly, Sanofi, Pfizer, Roche, AbbVie, Amgen, Merck & Co, Novo Nordisk, BMS,... Jersey Shore • Mar 6, 2020
The Press of Atlantic City Global Cancer Supportive Care Market 2020-2024 | Evolving Opportunities With Amgen Inc. and Baxter International Inc. | Technavio Jersey Shore • Mar 6, 2020
The Press of Atlantic City Global Regenerative Medicine Market 2020-2024 | Evolving Opportunities with Allergan Plc and Amgen Inc. | Technavio Jersey Shore • Feb 18, 2020
The Press of Atlantic City Global Gene Therapy Market Outlook and Projections, 2019-2027, Featuring Profiles of the Top 5 Players: Novartis, Amgen, Orchard Therapeutics, Kite Pharma, and uniQure... Jersey Shore • Jan 10, 2020
The Press of Atlantic City Analysis on the World's $140+ Billion Pain Management Drugs Market, 2019-2024 - Featuring Novartis, Eli Lilly, Amgen, GSK, AbbVie, and More - ResearchAndMarkets.com Jersey Shore • Dec 23, 2019
The Press of Atlantic City Amgen Gift to Fund Launch of KGI Center for Training in Applied Genomics Jersey Shore • Dec 5, 2019
The Press of Atlantic City Revolution Medicines and Amgen Partner on Phase 1b Study to Evaluate Combination of RMC-4630 and AMG 510 Jersey Shore • Nov 4, 2019
The Press of Atlantic City AT&T and Acadia post gains while Clorox and Amgen stumble Jersey Shore • Sep 9, 2019
Daily Mail on New Jersey Amgen to buy Celgene psoriasis drug Otezla for $13.4 billion New Jersey Non-Local Sources • Aug 26, 2019
New Jersey Law Journal Amgen Has 10 Billion Reasons to Cheer Patent Validity Ruling New Jersey Business • Aug 14, 2019
ABC News on New Jersey Amgen and Sysco rise while Viacom and Bank of America fall New Jersey Non-Local Sources • Aug 12, 2019
Daily Mail on New Jersey Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis New Jersey Non-Local Sources • Aug 9, 2019
Daily Mail on New Jersey U.S. court upholds Amgen patents on arthritis drug Enbrel New Jersey Non-Local Sources • Aug 9, 2019
The Press of Atlantic City Apple, Amgen rise; Molson Coors, Dine Brands fall Jersey Shore • Jul 31, 2019
ABC News on New Jersey Amgen and PHV rise while Alphabet and Centene slip New Jersey Non-Local Sources • Jun 3, 2019